|
|
|
|
Published online before print
June 28, 2007, 10.1101/gr.6468307 Genome Res. 17:1195-1201, 2007 ©2007 by Cold Spring Harbor Laboratory Press; ISSN 1088-9051/07 $5.00 OPEN ACCESS ARTICLE
Methods Characterization of mutation spectra with ultra-deep pyrosequencing: Application to HIV-1 drug resistance1 Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California 94305, USA; 2 Stanford Genome Technology Center, Stanford University, Stanford, California 94305, USA
The detection of mutant spectra within a population of microorganisms is critical for the management of drug-resistant infections. We performed ultra-deep pyrosequencing to detect minor sequence variants in HIV-1 protease and reverse transcriptase (RT) genes from clinical plasma samples. We estimated empirical error rates from four HIV-1 plasmid clones and used them to develop a statistical approach to distinguish authentic minor variants from sequencing errors in eight clinical samples. Ultra-deep pyrosequencing detected an average of 58 variants per sample compared with an average of eight variants per sample detected by conventional direct-PCR dideoxynucleotide sequencing. In the clinical sample with the largest number of minor sequence variants, all 60 variants present in
3 These authors contributed equally to this work. E-mail rshafer{at}stanford.edu; fax (650) 725-2088. [Supplemental material is available online at www.genome.org. The raw data from this study are available online at http://dbpartners.stanford.edu/454/pub.] Article published online before print. Article and publication date are online at http://www.genome.org/cgi/doi/10.1101/gr.6468307
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||